Ozempic, Wegovy drive Novo Nordisk profits up

Shares of Danish drugmaker Novo Nordisk fell on Thursday, as investors digested the latest hard numbers from the maker of heavily-hyped drugs Ozempic and Wegovy.

For the record, sales of both continue to explode, though sales of Wegovy, which more than doubled to kr. 9.8B, came in about 10% below analyst expectations. Ozempic sales, which slowed, actually were better than expectations.

In Danish currency terms, Q1 profit jumped 28% for the company, which is based in suburban Copenhagen. Novo Nordisk’s market value of roughly $570 billion is now larger than the entire Danish economy.

More Markets

See all Markets

Matt Phillips16m

Cisco’s quarterly results beat expectations for sales and EPS

Cisco beat Wall Street expectations for sales and earnings in its fiscal second-quarter results, which it released after the close of trading Wednesday.

For the fiscal second quarter of 2026, the computer networking equipment giant reported:

Non-GAAP earnings per share of $1.04 vs. the $1.02 expected by Wall Street analysts, according to FactSet.
Sales of $15.35 billion vs. the $15.11 billion consensus expectation.

Along with other companies like Lumentum, Corning, and new S&P 500 member Ciena, which provide things like the wiring and networking equipment needed to connect server racks, Cisco shares have had a strong start to 2026 as the AI data center boom continues to roll.

This is a developing story.

J. Edward Moreno17m

McDonald's Q4 earnings, sales beat Wall Street estimates

McDonald’s reported Q4 results on Wednesday that beat Wall Street’s expectations, which the company attributes to its "value leadership."

For the last three months of 2025, the fast food giant reported:

Adjusted earnings per share of $3.12, compared to $3.05 analysts polled by FactSet were expecting.
Revenue at $7 billion, higher than the $6.8 billion analysts were penciling in.
Global comparable sales growth of 5.7%, compared to the 3.9% growth analysts were expecting. In the US, comparable sales grew 6.8% compared to the 5.4% that was expected. The company said this was driven by "driven by positive check and guest count growth primarily from successful marketing promotions."

McDonald's has emphasized discounts and promotions, such as its $5 meal deals. “McDonald's value leadership is working,” CEO Chris Kempczinski said in a statement.

Shares were little changed in after-hours trading.

Luke Kawa

18m

AppLovin delivers top and bottom line beats in Q4 with Q1 guidance ahead of estimates

The adtech company just released Q4 results

Tasha Matsumoto

28m

Stocks finish flat after blockbuster jobs report

Employers added 130,000 jobs last month, crushing estimates for 65,000.

BISHOP'S STORTFORD, ENGLAND - JANUARY 25: Snowfall in the Essex countryside on January 25, 2021 in Bishop's Stortford, Essex, United Kingdom.

J. Edward Moreno4h

Gilead rises after earnings beat driven by HIV drug sales

Gilead rose more than 5% on Wednesday after it reported quarterly earnings and revenue that beat Wall Street estimates, driven by sales of its HIV drugs.

For the last three months of 2025, Gilead reported:

Adjusted earnings per share of $1.86, compared to the $1.81 the Street was expecting.
$7.9 billion in revenue, more than the $7.6 billion the Street was penciling in. Late last year the company began selling Yeztugo, a twice-yearly HIV prevention shot. CEO Daniel O’Day told analysts it “has already exceeded our coverage goals and is rapidly gaining market share.”

For the full year in 2026, the company expects:

Adjusted earnings per share of $8.45 to $8.85, compared to the $8.79 analysts forecast.
Revenue of $29.6 billion to $30 billion, compared to the $29.92 billion the Street was expecting. The company anticipates Yeztugo will contribute $800 million in revenue in 2026.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.